Sexually Transmitted Infections
Aptima®Combo 2 Assay (for CT/NG)
The Aptima Combo 2® assay delivers reliable results from multiple specimen types, including self and clinician-collected vaginal swabs with the Aptima® Multitest Swab – the preferred specimen type of the CDC for CT and NG testing.
Aptima® Trichomonas Vaginalis Assay
A highly sensitive and specific test to detect an extremely prevalent STI. With 2.6 million TV infections in the United States, a highly sensitive nucleic acid amplification test (NAAT) like the Aptima Trichomonas vaginalis assay is key for diagnosing and treating infections.
Aptima® Mycoplasma Genitalium Assay
A highly sensitive NAAT that seamlessly integrates into your lab’s workflow to confirm M. gen. Testing for M. gen is recommended by the Centers for Disease Control and Prevention (CDC) for patients with persistent or recurrent cervicitis and urethritis, and should be considered for those with pelvic inflammatory disease (PID).
Aptima® Herpes Simplex 1 & 2 Assay
NAATs, such as the Aptima® HSV 1 & 2 assay, are recommended by the CDC and WHO for HSV diagnosis. They are increasingly preferred over viral culture to diagnose genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.
Aptima® Neisseria Gonorrhoeae Assay
The Aptima® Neisseria gonorrhoeae (GC) assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Panther® System.
Aptima® Chlamydia Trachomatis Assay
A standalone NAAT for the detection of rRNA from Chlamydia trachomatis to aid in the diagnosis of chlamydial urogenital disease using the Panther® System. Provide excellent performance and an alternative option for the detection of chlamydia.
